This commentary highlights risks of MERS-CoV as a zoonotic virus, suggesting urgent pandemic preparedness and surveillance measures.
The COVID-19 pandemic demonstrated the lethal potential of emerging zoonotic viruses, particularly coronaviruses. While global attention has largely centered on SARS-CoV-2, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) remains an overlooked yet credible pandemic threat. The objective of this commentary is to spotlight the virological, epidemiological, and evolutionary features of MERS-CoV and its potential to trigger the next coronavirus pandemic. MERS-CoV, characterized by its high case fatality rate (~ 34%) and persistent circulation in dromedary camels, continues to cause sporadic outbreaks with limited human-to-human transmission. However, the inherent mutability of RNA viruses raises concerns that adaptive mutations could enhance MERS-CoV's transmissibility, potentially transforming it into a highly contagious human pathogen. This commentary revisits the virology, epidemiology, and zoonotic dynamics of MERS-CoV, highlighting the risks posed by viral evolution, the ongoing "slow burn" of zoonotic spillovers, and the dangers of post-pandemic complacency. We argue for renewed investment in surveillance, vaccine development, and proactive public health measures, grounded in a One Health approach. Vigilant monitoring of MERS-CoV and other emerging pathogens is essential to prevent future pandemics and to avoid being caught off guard once again.
No takes yet. Share an insight, caveat, or question.
Goshen David Miteu (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: